You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 1
  • 4CPS-233 PD-l1 expression and histological type as predictors of response in metastasic non-small-cell lung cancer (NSCLC) patients treated with pembrolizumab in first-line

Article metrics

Article menu

Download PDFPDF

Section 4: Clinical pharmacy services
4CPS-233 PD-l1 expression and histological type as predictors of response in metastasic non-small-cell lung cancer (NSCLC) patients treated with pembrolizumab in first-line
Free

 

Online download statistics by month:

Online download statistics by month: March 2023 to September 2024

AbstractFullPdf
Mar 20232003
Apr 20233207
May 20232603
Jun 20232004
Jul 20231603
Aug 20231203
Sep 2023705
Oct 2023400
Nov 20231503
Dec 20231402
Jan 20241000
Feb 2024701
Mar 20241207
Apr 20241401
May 2024602
Jun 20241201
Jul 2024303
Aug 2024701
Sep 20241203
Total249052